Benzinga | Nov 11, 2021 02:27PM EST

Ocugen Issues Statement Regarding Publication Of COVAXIN (BBV152) Phase 3 Study Results In The Lancet

https://ocugen.gcs-web.com/news-releases/news-release-details/ocugen-statement-regarding-publication-covaxintm-bbv152-phase-3